Evaluation of the Safety of Reoperation for Ipsilateral Recurrent Tumors After Nephron-sparing Partial Nephrectomy

Reoperation for Ipsilateral Local Recurrence Following Prior Nephron-sparing Surgery: Innovative Surgical Insights From a High-volume Urological Center

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06317207

Acronym

LiangAH

Enrollment

Registered

2024-03-19

Start date

2013-01-01

Completion date

2023-12-31

Last updated

2024-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cell Carcinoma, Robotic Surgical Procedures

Brief summary

To evaluate the safety of reoperation in patients with renal tumors who have ipsilateral tumor recurrence after nephron-sparing partial nephrectomy.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

1\. ipsilateral local rRCC (any recurrence in the ipsilateral kidney and retroperitoneum)

Exclusion criteria

1. With distant metastasis; 2. Lacking essential sugery information.

Design outcomes

Primary

Measure	Time frame	Description
Operation time	1 week	Operation time

Secondary

Measure	Time frame	Description
Estimated blood loss	1 week	Estimated blood loss

Outcome results